Cryo Electron Microscopy Market, By Product Type (Transmission Electron Microscopes, Scanning Electron Microscopes Accessories and Software), By Application (Biological Science, Material Science, Nanotechnology, Lifesciences, Medical, Semiconductor, Other

Cryo Electron Microscopy Market, By Product Type (Transmission Electron Microscopes, Scanning Electron Microscopes Accessories and Software), By Application (Biological Science, Material Science, Nanotechnology, Lifesciences, Medical, Semiconductor, Others), By End-User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Government and Research Laboratories, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


The global cryo electron microscopy market has been gaining significant traction over the past few years. Cryo electron microscopy is a specialized technique that uses low temperature electron microscopy to obtain structural and functional information about biological molecules and assemblies. It offers several advantages over other high-resolution microscopy techniques such as x-ray crystallography, as it does not require crystallizing the sample and can image non-symmetric and highly flexible molecules. Growing biomedical R&D expenditures as well as increasing government funding for structural biology projects are some of the key factors driving the adoption of cryo electron microscopy in research and development. With continued technological advancements, the global cryo electron microscopy market is expected to grow at a robust pace during the forecast period.

Market Dynamics:

The global cryo electron microscopy market is witnessing strong growth driven by a few key factors. Rising investments in structural biology and macromolecular research by pharmaceutical companies and academic institutes is a major growth driver. Increasing popularity of cryo-EM over traditional x-ray crystallography for studying disease mechanisms at the molecular level is bolstering demand. Continuous technological advancements aimed at improving resolution capabilities and expanding applications are also propelling the market forward. However, high costs of cryo electron microscopy systems and dearth of skilled workforce are some of the key challenges restraining widespread adoption. On the other hand, development of user-friendly cryo-EM software and emergence of correlative light and electron microscopy present significant opportunities for market players.

Key features of the study:
  • This report provides in-depth analysis of the global cryo electron microscopy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cryo electron microscopy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific, JEOL Ltd., Hitachi, and Carl Zeiss AG
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cryo electron microscopy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cryo electron microscopy market.
Detailed Segmentation:
  • By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Transmission Electron Microscopes (TEM)
  • Single Particle Analysis
  • Electron Tomography
  • Scanning Electron Microscopes (SEM)
  • Cryo-Scanning Electron Microscopy (Cryo-SEM)
  • Correlative Light-Electron Microscopy (CLEM)
  • Accessories and Software
  • Specimen Preparation
  • Image Processing and Analysis
  • By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Biological Science
  • Material Science
  • Nanotechnology
  • Lifesciences
  • Medical
  • Semiconductor
  • Others
  • By End-user Insights (Revenue, USD Bn, 2019 - 2031)
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Government and Research Laboratories
  • Others
  • By Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Thermo Fisher Scientific
  • Danaher
  • JEOL
  • Intertek Group
  • Charles River Laboratories
  • Hitachi High-Technologies
  • Carl Zeiss
  • Gatan, Inc.
  • Oxford Instruments
  • Olympus Corporation
  • Leica Microsystems
  • KEYENCE CORPORATION
  • Molecular Devices, LLC
  • Nikon Instruments
  • Caliber Imaging & Diagnostics
  • Lasertec Corporation
  • Thorlabs, Inc.
  • Hamamatsu Photonics
  • NanoFocus AG
  • HORIBA, Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Bortezomib Market, By Product Type
Global Bortezomib Market, By Application
Global Bortezomib Market, By End User
Global Bortezomib Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Bortezomib Market, By Product Type, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Powder for Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Bortezomib Market, By Application, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Multiple Myeloma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Mantle Cell Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Hematological Malignancies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Bortezomib Market, By End User, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Oncology Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others (Research Institutes, Cancer Centers)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Bortezomib Market, By Region, 2019 - 2031, (USD Mn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
Market Y-o-Y Growth Analysis (%), 220 - 2031, (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Mn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Hikma Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Meitheal Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis International AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
NATCO Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Reddy's Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Gland Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Shilpa Medicare
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Qilu Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Scion Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Farmhispania Group
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Coresyn
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Chem-Stone (Guangzhou)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Hubei Honch Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Vinkem Labs
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Icrom
TAPI Teva
Chengdu Aslee Biopharmaceuticals
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ' Bortezomib Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings